Imarc
IMARC Research is a woman-owned medical device CRO providing full-service clinical trial support, including monitoring, auditing, safety oversight, project management, data management, consulting, and online training, to medical device manufacturers across nine therapeutic verticals.
- Company typePrivate
- Founded2000
- HeadquartersStrongsville, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Imarc does
IMARC Research, Inc. is a woman-owned, privately held Contract Research Organization (CRO) founded around 1999–2000 and headquartered in Strongsville, Ohio, with an additional office in Minneapolis. The company provides full-service clinical research support exclusively to medical device manufacturers, spanning the entire clinical trial lifecycle: regulatory strategy and protocol development, monitoring, auditing, safety oversight (DSMB/CEC), project management, data management, site support, consulting, and training. Its therapeutic coverage includes cardiovascular, orthopaedics, women's health, in vitro diagnostics, biologics, wound care, neurovascular, dental, and pain management.
The company's core technology stack centers on risk-based monitoring and compliance oversight tooling, including remote monitoring capabilities, electronic Trial Master File (eTMF) systems, IRB portal access, and remote EMR connectivity. IMARC has also developed proprietary intellectual property in the form of the FAIR Shake Training Method, a risk-based monitoring methodology, and the IMARC University online training platform. The firm holds ISO 9001:2008 certification (achieved 2014) and has built a multi-channel thought leadership engine (blog, whitepapers, webinars, ACRP conference participation) to generate top-of-funnel demand.
IMARC monetizes through professional services engagements negotiated on a project-by-project basis with medical device sponsors, supplemented by subscription-based revenue from IMARC University's online clinical research training courses. Distribution is direct enterprise field sales with no intermediary channels. The company has a minor European CRO partnership supporting multi-region regulatory compliance, but there is no disclosed outside funding, indicating the firm is bootstrapped and self-sustaining. Leadership consists of co-founder and CEO Sandra Maddock and President Brandy Chittester.
Imarc firmographics
Firmographics- Name
- Imarc
- Legal name
- IMARC RESEARCH, INC.
- Website
- https://imarcresearch.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- IMARC Research is a woman-owned medical device CRO providing full-service clinical trial support, including monitoring, auditing, safety oversight, project management, data management, consulting, and online training, to medical device manufacturers across nine therapeutic verticals.
- Ownership category
- akta.pro rank
Imarc industry classification
Industry- Product category
- Medical Device Contract Research Organization (CRO) Services
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)
Keywords
Where Imarc is headquartered
LocationHeadquarters
- HQ city
- Strongsville
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Imarc business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Clinical Research Services: Professional services revenue generated through providing comprehensive CRO services to medical device companies including monitoring, auditing, safety monitoring, project management, data management, site support, consulting, and training throughout the clinical trial lifecycle.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Online clinical research training courses |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
Imarc product offering
Product offeringCore offering
IMARC is a medical device Contract Research Organization (CRO) that provides full-service clinical research support to medical device manufacturers, spanning monitoring, auditing, safety monitoring, project management, data management, site support, consulting, and training across the entire clinical trial lifecycle. The company helps sponsors navigate FDA and international regulations (510(k), PMA, EU MDR) while protecting human subjects and maintaining data integrity, and supplements its CRO services with online clinical research training through IMARC University.
Product overview
IMARC is a woman-owned Medical Device CRO offering a comprehensive suite of clinical research services organized around their Clinical Trial Lifecycle Framework. The core offering consists of eight integrated service lines: Monitoring, Auditing, Safety Monitoring, Project Management, Data Management, Site Support, Consulting, and Training. These services support medical device companies throughout the entire clinical trial process—from regulatory strategy and protocol development through study implementation, ongoing oversight, and final study closeout. Additionally, IMARC offers proprietary training products through IMARC University using their FAIR Shake methodology, along with an extensive library of whitepapers, case studies, and resource materials. The company specializes in therapeutic areas including cardiovascular, orthopaedics, women's health, in vitro diagnostics, biologics, wound care, neurovascular, dental, and pain management.
Differentiator
Problem solved
Functional benefit
Brands
- IMARC University: Online clinical research training platform offering courses for clinical research professionals including monitors, research coordinators, investigators, and project managers.
Products and services
- Medical Device CRO Services Full-service Contract Research Organization providing comprehensive clinical research support for medical device companies, from planning through post-market data collection.
- Clinical Research Monitoring Core monitoring service providing on-site and remote oversight of clinical trials to ensure compliance, data integrity, and patient protection.
- Clinical Research Auditing Auditing services for clinical investigations to ensure regulatory compliance and identify areas for improvement.
- Safety Monitoring Safety monitoring services including DSMB and CEC oversight to protect study participants and ensure data integrity.
- Clinical Research Project Management Project management services to coordinate all aspects of clinical trials, managing resources, timelines, and stakeholder communications.
- Clinical Research Data Management Data management services for collecting, organizing, and validating clinical trial data.
- Clinical Research Site Support Support services for clinical research sites including research coordinator support and remote site assistance.
- Clinical Research Consulting Consulting services to advise medical device companies on regulatory strategy, compliance, and clinical trial planning.
- IMARC University Online and in-person clinical research training platform offering courses for clinical research associates, monitors, research coordinators, investigators, and project managers through individual courses, role-based courses, and course packages, with reduced pricing and continuing education credits.
Quantifiable outcome
- 80% of clinical trials experience delays of 1-6 months, costing thousands of dollars per day; proper risk assessment and mitigation planning helps avoid these costly delays
Companies that use Imarc
Customer profileSegments1 record
Ideal customer profiles2 records
Imarc technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Imarc partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- European CRO PartnershipminorIMARC signed an agreement with a European CRO to expand their global capabilities and ensure clinical trial compliance across international regulatory frameworks.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Imarc competitors and assessment
Company assessmentBroad incumbents
- Charles River Laboratories: Charles River is a large, publicly traded CRO/CDMO with medical device research services via its RMS business. Overlaps with IMARC on device clinical and safety monitoring but as part of a much broader portfolio.
- IQVIA: IQVIA is the world's largest CRO with broad device and diagnostics capabilities. Competes with IMARC on enterprise device trial programs but operates at vastly greater scale and geographic reach.
- Eurofins Medical Device Services: Eurofins provides medical device testing, clinical research, and regulatory consulting globally, overlapping with IMARC's clinical monitoring and compliance offerings as part of a broader testing/services portfolio.
Direct peers
- Clinipace Worldwide: Clinipace is a smaller, full-service CRO with medical device and oncology focus, serving mid-sized sponsors. Comparable size and service mix to IMARC, targeting similar FDA submission pathways.
- Premier Research: Premier Research is a specialty CRO with deep medical device and rare disease expertise, offering clinical monitoring, regulatory, and biometrics services — directly comparable to IMARC's service mix and device sponsor focus.
- Veranex (formerly RCRI): Veranex is a medtech-focused CRO and regulatory services provider offering clinical, preclinical, and design services to medical device companies. Direct overlap with IMARC's device clinical and regulatory support.
- MedPace: MedPace is a mid-sized full-service CRO with a strong medical device and diagnostics practice, competing head-to-head with IMARC for device-sponsored clinical trials and FDA approval support.
- Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized CRO offering full-service clinical research including for medical device and specialty therapeutics, with comparable sponsor base and service breadth to IMARC.
- NAMSA: NAMSA is the largest medical device-focused CRO, offering preclinical, clinical, and regulatory services to medical device manufacturers globally. Direct overlap with IMARC across medical device clinical monitoring, regulatory strategy, and FDA submission support.
- Emmes Corporation: Emmes is a privately held CRO with medical device, biologics, and ophthalmology clinical research expertise, offering comparable full-service clinical research support to mid-sized device sponsors.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Imarc social profiles
Digital presenceImarc compliance and trust
Trust signalCompliance1 record
Imarc financial estimates
Financial estimateRevenue estimate
Valuation estimate
Imarc leadership team
Management profileNumber of profiles
Profiles3 records
Imarc funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Imarc M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Imarc
What does Imarc do?
IMARC is a medical device Contract Research Organization (CRO) that provides full-service clinical research support to medical device manufacturers, spanning monitoring, auditing, safety monitoring, project management, data management, site support, consulting, and training across the entire clinical trial lifecycle. The company helps sponsors navigate FDA and international regulations (510(k), PMA, EU MDR) while protecting human subjects and maintaining data integrity, and supplements its CRO services with online clinical research training through IMARC University.
Is Imarc a public or private company?
Imarc is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Imarc founded?
Imarc was founded in 2000. It employs 101 to 250 people.
Where is Imarc based?
Imarc is headquartered in Strongsville, United States, in the North America region.
How does Imarc make money?
One revenue line is on record: clinical Research Services.
Who are Imarc's main competitors?
Broad incumbents on record are Charles River Laboratories, IQVIA and Eurofins Medical Device Services. Direct peers are Clinipace Worldwide, Premier Research, Veranex (formerly RCRI), MedPace, Worldwide Clinical Trials, NAMSA and Emmes Corporation.
Does Imarc have an API?
No public API is recorded for Imarc.
What industry is Imarc in?
Imarc's product category is Medical Device Contract Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAH, Pharmacovigilance, Risk Management & Medical Affairs CROs.